Pregnenolone Can Protect the Brain from Cannabis Intoxication

Monique Vallée(Université de Bordeaux), S. Vitiello(Université de Bordeaux), Luigi Bellocchio(Université de Bordeaux), Étienne Hébert-Chatelain(Université de Bordeaux), Stéphanie Monlezun(Amplitude Systèmes (France)), Elena Martín‐García(Universitat Pompeu Fabra), Fernando Kasanetz(Université de Bordeaux), Gemma L. Baillie(University of Aberdeen), Francesca Panin(Université de Bordeaux), Adeline Cathala(Université de Bordeaux), Valérie Roullot-Lacarrière(Université de Bordeaux), Sandy Fabre(Amplitude Systèmes (France)), Dow P. Hurst(University of North Carolina at Greensboro), Diane L. Lynch(University of North Carolina at Greensboro), Derek M. Shore(University of North Carolina at Greensboro), Véronique Deroche‐Gamonet(Université de Bordeaux), Umberto Spampinato(Université de Bordeaux), Jean‐Michel Revest(Université de Bordeaux), Rafaël Maldonado(Universitat Pompeu Fabra), Patricia H. Reggio(University of North Carolina at Greensboro), Ruth A. Ross(University of Aberdeen), Giovanni Marsicano(Université de Bordeaux), Pier Vincenzo Piazza(Université de Bordeaux)
Science
January 2, 2014
Cited by 313Open Access
Full Text

Abstract

Pregnenolone is considered the inactive precursor of all steroid hormones, and its potential functional effects have been largely uninvestigated. The administration of the main active principle of Cannabis sativa (marijuana), Δ(9)-tetrahydrocannabinol (THC), substantially increases the synthesis of pregnenolone in the brain via activation of the type-1 cannabinoid (CB1) receptor. Pregnenolone then, acting as a signaling-specific inhibitor of the CB1 receptor, reduces several effects of THC. This negative feedback mediated by pregnenolone reveals a previously unknown paracrine/autocrine loop protecting the brain from CB1 receptor overactivation that could open an unforeseen approach for the treatment of cannabis intoxication and addiction.


Related Papers

No related papers found

Powered by citation graph analysis